Home / Development of a Scalable, Racemic First-Generation Route for CXCR7 Antagonist ACT-1004-1239 via cis-to-trans Epimerization and Subsequent Separation of Enantiomers Development of a Scalable, Racemic First-Generation Route for CXCR7 Antagonist ACT-1004-1239 via cis-to-trans Epimerization and Subsequent Separation of Enantiomers Gabriel Schäfer Tony Fleischer Muhamed Ahmetovic Philippe Guerry & Stefan Abele ★ 5.0 · 205 reads Sign in to save this Request CodeZLIB.IO18513456 Published2022 Pages1 LanguageUnknown
